These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19072635)

  • 1. Pharmacoepigenetics and pharmacoepigenomics.
    Peedicayil J
    Pharmacogenomics; 2008 Dec; 9(12):1785-6. PubMed ID: 19072635
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoepigenetics and Pharmacoepigenomics: An Overview.
    Peedicayil J
    Curr Drug Discov Technol; 2019; 16(4):392-399. PubMed ID: 29676232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepigenetics: its role in interindividual differences in drug response.
    Gomez A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.
    Lopomo A; Coppedè F
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):49-62. PubMed ID: 28856927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics.
    Cascorbi I
    Pharmacogenomics; 2013 Nov; 14(15):1807-9. PubMed ID: 24236479
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis and treatment response in complex diseases.
    Banerjee M
    Pharmacogenomics; 2022 Jan; 23(2):81-84. PubMed ID: 34842441
    [No Abstract]   [Full Text] [Related]  

  • 7. Do pharmacogenetics, genomics and epigenetics hold promise for molecular therapeutics and health?
    Huber LA
    Curr Opin Mol Ther; 2010 Jun; 12(3):268-9. PubMed ID: 20556904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.
    Smits KM; Cleven AH; Weijenberg MP; Hughes LA; Herman JG; de Bruïne AP; van Engeland M
    Pharmacogenomics; 2008 Dec; 9(12):1903-16. PubMed ID: 19072647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic techniques in pharmacogenetics.
    Heil SG
    Methods Mol Biol; 2013; 1015():179-88. PubMed ID: 23824856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic mechanisms underlying unanticipated drug responses.
    Carlquist JF; Anderson JL
    Discov Med; 2011 May; 11(60):469-78. PubMed ID: 21616045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of pain and analgesia.
    Smith MT; Muralidharan A
    Clin Genet; 2012 Oct; 82(4):321-30. PubMed ID: 22779698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: the importance of accurate phenotypes.
    Gurwitz D; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):469-70. PubMed ID: 20350123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaco(epi)genomics in ovarian cancer.
    Paige AJ; Brown R
    Pharmacogenomics; 2008 Dec; 9(12):1825-34. PubMed ID: 19072641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems approaches for pharmacogenetics and pharmacogenomics.
    Bader JS
    Pharmacogenomics; 2008 Mar; 9(3):257-62. PubMed ID: 18303961
    [No Abstract]   [Full Text] [Related]  

  • 17. Symbiotic relationship of pharmacogenetics and drugs of abuse.
    Rutter JL
    AAPS J; 2006 Mar; 8(1):E174-84. PubMed ID: 16584126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and personalized medicine.
    Li-Wan-Po A
    J Clin Pharm Ther; 2012 Dec; 37(6):617-9. PubMed ID: 23013532
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of being modest--reflections on the pharmacogenetics of abacavir.
    Lindpaintner K
    Pharmacogenomics; 2002 Nov; 3(6):835-8. PubMed ID: 12437485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacogenetics II. Research molecular methods, bioinformatics and ethical concerns].
    Daudén E
    Actas Dermosifiliogr; 2007; 98(1):3-13. PubMed ID: 17374327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.